跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lung-H1
首页
药物
Lung-H1
Lung-H1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTI-B7-H1 AND ANTI-CTLA-4 ANTIBODIES FOR TREATING NON-SMALL CELL LUNG CANCER
EP 3142751 B1
申请人: MEDIMMUNE LTD
优先权: 2014
EP
US
WO
8 件公开
Tubematricoside B in preparation of medicine for preventing angiogenesis, tumor invasion and transfer
CN 101073578 A
申请人: YU TINGXI
优先权: 2006
CN
Tubeimoside ó± for the preparing of the medicine for resisting the growth, invasion and transfer of the knub
CN 101095687 A
申请人: UNIV GUANGDONG OCEAN
优先权: 2006
CN
Construction and use of lentivirus-mediated siRNA (small interfering RNA) recombinant 970 against VEGF-C (vascular endothelial growth factor C) gene
CN 102533763 A
申请人: YUKUAN FENG
优先权: 2011
CN
LUNG CANCER THERAPY WITH A RODENT PARVOVIRUS
EP 3069724 A1
申请人: DEUTSCHES KREBSFORSCH
优先权: 2015
EP
Platinum substances with structural formulas H1 and H2 as well as preparation and application thereof
CN 111718377 A
申请人: HAINAN CHANGAN INT PHARMACEUTICAL CO LTD
优先权: 2019
CN
Method for treating non-small cell lung cancer based on personalized modified dendritic cells
CN 116459334 A
申请人: SHENZHEN JUNYUAN BIOTECHNOLOGY CO LTD
优先权: 2023
CN
Application of inhibiting proliferation and growth of cancer cells by expressing and connecting H1.4 C terminal of histone H1 family member
CN 119824041 A
申请人: UNIV ANHUI
优先权: 2024
CN
Intelligent nanometer classifier based on glutathione gating and preparation method and application thereof
CN 121987782 A
申请人: UNIV SOUTHEAST
优先权: 2026
CN
药物
反馈